EP1024858A1 - Vorrichtung und verfahren zum aktivieren von objekten - Google Patents
Vorrichtung und verfahren zum aktivieren von objektenInfo
- Publication number
- EP1024858A1 EP1024858A1 EP98956864A EP98956864A EP1024858A1 EP 1024858 A1 EP1024858 A1 EP 1024858A1 EP 98956864 A EP98956864 A EP 98956864A EP 98956864 A EP98956864 A EP 98956864A EP 1024858 A1 EP1024858 A1 EP 1024858A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- magnetic field
- activated
- antenna
- activation
- magnetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
Definitions
- the invention relates to a device for activating objects in the form of substances, organic materials or living plant, animal or human bodies and parts thereof according to the preamble of claim 1 and a method for activating objects in the form of substances, organic materials or living plant Bodies and parts thereof according to claim 23.
- Bioresonance therapy is essentially based on the following prerequisites:
- the body and biochemical processes in the body are controlled electromagnetically, ie there are electro-magnetic vibrations in and around the human body. These are superior to the biochemical processes and control them, so that an oscillation spectrum of the organism is created.
- there are also pathological vibrations in every person which are caused by toxin loads, injuries, infections, unhealed diseases, allergies, etc.
- Corresponding vibrations are present in fabrics.
- the body's or substance's own electromagnetic fields can be tapped from the surface and processed in a therapy device. Therapy vibrations are generated in the therapy devices from these vibrations, which are fed to the body.
- the therapy vibrations cause a therapeutic effect in the patient's body by deleting or reducing the pathological vibrations or stimulating or strengthening the physiological vibrations.
- the improvement of the biophysical energy situation leads to an effective therapy.
- This form of therapy has been known for twenty years, whereby the term mora ( R ) therapy was first coined and the term bioresonance has recently become established.
- mora ( R ) therapy was first coined and the term bioresonance has recently become established.
- the techniques of bioresonance therapy are referred to in the relevant literature, for example the publication by F. Morell in holistic medicine, issue 0 / 4-87, page 17 and by W. Ludwig, The Basics of Bioresonance Therapy, from Biore - Sonance and multi-resonance therapy, Haug Verlag 1990, referred.
- the physical description for the electromagnetic radiation of substances in the long-wave range can be found using the Rayleigh-Jeans law.
- the radiation curve of a black body has a maximum at lO ⁇ m at a temperature of 300 K, ie in the IR range. According to the radiation laws, radiation can also be found at low frequencies. So z. B. between 0.9 and 1.1 MHz an emission of approx. 8700 photons per cm ⁇ and second can be expected. These values are modified for a real body compared to the black body. The difference from a hypothetical black body explains the different spectral radiation from different materials.
- the characteristic radiation emitted by each substance which is in both the low and high frequency range, can be picked up by an input antenna and processed with an electronic circuit, e.g. B. amplified, inverted or weakened.
- this processed signal can be swung onto a carrier that can store this oscillation pattern or onto a body.
- the swinging up is the common name for the transmission of a signal.
- the transmitter substance can be a natural or artificial preparation or an endogenous substance. Swinging up on a body is a therapeutic application.
- the so-called MitoSan system is manufactured by Vitatec GmbH medical-technical products and distributed in which objects to be treated or activated are exposed to a weakly varying magnetic field.
- the MitoSan system can also generate vibrations in the area of ultra-weak electromagnetic signals. These ultra-weak signals correspond to those of the cell itself under physiological conditions and within the framework of genetic control. If these ultra-weak signals are missing from the patient, the organism is stimulated by the application of the vibration patterns of MitoSan therapy to rebuild them itself; the pathological cell system can regenerate.
- a disadvantage of the known therapy devices or devices for irradiating and activating objects is that the influence of the temporally and locally changing geomagnetic field is not taken into account.
- the earth's magnetic field influences the activation of objects.
- the effect of magnetic fields on objects to be activated can be explained in such a way that the movements of charged particles such as ions, charged molecules, atomic nuclei or electrons are influenced by a magnetic field. With the help of a magnetic field, energy can be transferred to charged particles and their orbital movement can be influenced.
- the resonance frequency - on substances that are in a magnetic field the substances to be activated absorb energy through resonance effects, which is then emitted again by emitting electromagnetic radiation.
- the radiation emitted in that case is characteristic of the substance for a given static magnetic field.
- the magnetic field In view of the fact that the body is exposed to the earth's magnetic field, the strength of which is on average between 20 T and 60 T, it can therefore be expected that the magnetic field will have an influence on disturbances in the body.
- the earth's magnetic field interacts with the existing electromagnetic field of terrestrial or extraterrestrial origin and triggers the resonance phenomena explained above. Since disturbances in the body occurred at a certain point in time with a certain magnetic field and a certain electromagnetic field, it can be explained that suitable states have to be set accordingly in order to remedy the stored disturbances.
- the earth's magnetic field which is also a weak magnetic field, is shielded from the object to be activated, the influence of the earth's magnetic field is eliminated.
- the magnetic field is shielded in the area of the object to be activated, i. H. the area in which the object to be activated is located is shielded.
- the shielding of the earth's magnetic field can be passive, e.g. B. by a material with high permeability ( ⁇ -metal, soft iron), or active, d. H. by an oppositely polarized artificially generated magnetic field.
- the shielding is designed in such a way that in the area in which the object to be activated is located, the earth's magnetic field and also from outside - artificial magnetic fields not generated by the device according to the invention - are shielded.
- the weak magnetic field generated by the device according to the invention can in principle be constant, i. H. be variably adjustable to a fixed value. However, it is preferred if the strength and / or direction of the magnetic field can be changed over time, since a human body also moves in the earth's field and is therefore exposed to different field values and field directions.
- the earth's magnetic field is subject to periodic fluctuations that repeat with a period of 13 hours up to a frequency of 22 kHz. The higher the frequency, the smaller the change in field strength.
- the earth's magnetic field and in particular the changes in the earth's magnetic field can be artificially simulated with the device according to the invention, with the shielding preventing the artificial "earth's magnetic field" from being superimposed on the natural earth's magnetic field.
- all relevant magnetic fields can thus be passed through in a defined manner without being superimposed on external magnetic fields, so that a precisely fitting signal is generated in any case. It has been found that the simulation of the change in the natural magnetic field over time with higher or lower field strengths than the natural magnetic field has a particularly favorable effect on the activation of substances and is also therapeutically more effective than the identical simulation of the earth's magnetic field.
- the temporal variation of the artificially generated magnetic field takes place with a frequency that is not too high, for example with a frequency of less than 10 Hz, in practice a slow change of the magnetic field over a period of about 30 seconds can also be advantageous it in view of the much shorter time constants that occur in the processes to be activated Material play a role as a quasi-static magnetic field.
- the object to be activated is shielded from external magnetic fields, such as earth's magnetic field or artificial magnetic fields caused by electrical devices, and exposed to a defined constant or variable magnetic field.
- the activation then takes place through the interaction of the weak magnetic field with the existing terrestrial and extraterrestial radiation, which is not shielded by the magnetic shielding.
- the activation is additionally carried out by means of thermal, electromagnetic, electrical, optical or magnetic excitation.
- the activation means here comprises an activation antenna arranged in the area of the object to be activated.
- this activating agent can be influenced and modulated in a targeted manner.
- a vibration pattern is derived from a radiating transmitter substance or the object to be activated by means of a receiving antenna, processed in a signal processing unit and transmitted to a carrier substance via a transmitting antenna.
- the solution according to the invention is based on the knowledge that it is possible! is ,, to excite the transmitter substances or substances to be activated thermally, electromagnetically, electrically or magnetically by means of an activation means, whereby the therapy signal picked up by the receiving antenna is stronger than the signal without activation or the signal with the appropriate amplitude or frequency for the respective application is produced.
- the signal intensity of a substance whose original radiation has weakened or has been lost can be excited again and used for the purposes described.
- the radiation according to the invention can be intensified. It can be assumed that an essentially reinforcing effect occurs with purely inorganic transmitter substances, since their emission decreases only very slowly over time. In other applications, a "suitable" signal can be provided.
- activation means are suitable for activating the transmitter substance, ie for supplying suitable energy, in particular in the form of vibrations.
- the activation means comprise an activation antenna. Using an activation antenna, electromagnetic vibrations can be applied to the transmitter material or to the object to be activated. jekt be transferred, the frequencies and the polarity are adjustable in the desired manner.
- the radiation device comprises both a magnetic activation means, that is to say a device for generating a magnetic field at the location of the transmitter substance or the object to be activated, and also a thermal or electromagnetic activation means.
- a magnetic activation means that is to say a device for generating a magnetic field at the location of the transmitter substance or the object to be activated
- a thermal or electromagnetic activation means enables intensive activation, especially at low frequencies. If you also use a delay circuit, the signal can continue to be optimally influenced for the effect to be achieved. In this case, the signals can also be stored.
- Another advantageous activating agent can be a light source. All types of lamps and light sources that emit continuously or at intervals, in particular flash lamps, miniaturized lasers and IR diodes, are suitable for this.
- Another advantageous activating agent can be a heat source.
- This can be, for example, a radiant heat source or a heating resistor in contact with the transmitter substance or its container.
- activating agents e.g. activating antenna, light source and heat source
- control unit or the activation means for sending a multitude of number of frequencies is formed by means of the activation means. It has been found within the scope of the invention that broadband excitations are particularly effective. It is therefore most advantageous if the largest possible frequency spectrum simultaneously acts on the transmitter substance for activation. The action can be constant or varying over time. However, it is also advantageous if a changing frequency, for example by means of a frequency generator, is used to achieve an activation comprising many frequencies. The frequencies can be between a few Hertz and 30 GHz.
- the activation means can be activated periodically or aperiodically in a pulsed manner. It has been found that activation, which does not take place permanently, but rather has rest periods for the transmitter substrate between the activation coils, is particularly advantageous in many areas of application. Furthermore, it can be advantageous, in particular in the case of electromagnetic activation by means of a transmitting antenna, if there are pauses in activation in which the physiological electromagnetic signal can be picked up by the transmitter material by means of the receiving antenna without a disruptive signal from the activating means, i.e. the activation antenna is superimposed.
- a preferred development can consist in that the activating agent in one of the two atmospheric
- Window is emitted and / or pulsed at a frequency in one of the two atmospheric windows. This is explained for the following reasons.
- the decisive factor here is the property of the atmosphere, certain electromagnetic frequencies better to let through than to weaken others and to almost zero.
- the second atmospheric window covers the electromagnetic frequency range from 3 MHz to 30 GHz.
- the activation means can be activated in a pulsed manner with a frequency between 7 and 9 Hz, preferably around 7.8 Hz.
- This aspect of the invention is based on the following knowledge. Man and his environment are in a kind of cavity resonator that influences and partially controls the organism. The cavity resonator is formed on one side by the earth's surface and on the other side by the Heaviside layer of the atmosphere. Thunderstorm activity and other atmospheric phenomena cause this cavity resonator to vibrate, the fundamental wave of the vibrations being approximately 7.8 Hz and the waves being called "Schumann waves". It has been found that this frequency of 7.8 Hz coincides with the hippocampal frequency, which is common to all Mammals are largely the same.
- the Schumann waves which can have varying frequencies, are pulse-shaped events that are composed of fundamental and harmonic waves.
- the nervous system responds to both the fundamental and the harmonic waves. This also applies to the objects to be activated.
- the signal processing stage comprises a delay circuit, by means of which output signals can be delayed in time compared to input signals.
- the processing unit can also be used to change the phase position of the signals picked up by the receiving antenna to the signals emitted by the transmitting antenna, as is known from German utility model 29709094.1. In this respect, reference is made here in full to this utility model.
- Fig. 1 is a schematic representation of a first embodiment of the invention
- Fig. 2 is a schematic representation of a second embodiment of the invention.
- Fig. 3 is a schematic representation of a third embodiment of the invention.
- FIG. 4 shows a schematic illustration of a fourth embodiment of the invention by means of which oscillation patterns can be transferred from a transmitter substance or an object to be activated to a carrier substance;
- FIG. 5 is a schematic illustration of a fifth embodiment of the invention, which is a modification of the fourth embodiment.
- Fig. 1 shows a schematic representation of a first embodiment of the invention.
- An object 2 to be activated is arranged inside a magnetic field coil 4.
- the magnetic field coil 4 is in turn arranged within a passive magnetic shield 6.
- the magnetic field coil 4 is controlled by means of a control unit 8.
- the magnetic field coil 4 serves both to generate a weak magnetic field as an activation means and to generate a correspondingly polarized shielding magnetic field, by means of which the earth's magnetic field and other external magnetic fields are compensated.
- magnetic field sensors 10 are arranged in the interior of the magnetic field coil 4 in the area of the object to be activated. These magnetic field sensors 10 deliver a manipulated variable for the magnetic field to be controlled inside the magnetic field coil 4.
- FIGS. 2 and 3 show a second and third embodiment of the invention, which is suitable for the treatment of the human body or parts thereof.
- a tubular housing 12 contains the magnetic field coil, shielding and magnetic field sensors, which are not shown, and which are controlled by the control unit 8.
- the housing 12 is large enough to accommodate a human body.
- the housing 12 is smaller and only serves to hold a foot, a hand or the like.
- FIGS. 4 and 5 show a fourth and fifth embodiment of the invention by means of which oscillation patterns can be transmitted from a transmitter substance 2 or an object 2 to be activated to a carrier substance 14 in a sectional illustration.
- the object to be activated or the transmitter material 2 and the carrier material 14 are each in a container 16 which is as broad as possible permeable to electromagnetic radiation and, for example, consists of quartz glass.
- An antenna 18 in the form of a spiral antenna is provided in the bottom region of the container 16 under the transmitter material 2.
- the antenna 18 serves both as an activation antenna for activating the transmitter substance 2 and as a reception antenna for receiving the signals originating from the transmitter substance 2.
- a transmitter fir 20 is arranged, which is also designed as a spiral antenna.
- the transmitter material 2 and the carrier material 14 are each inserted into cup-shaped receptacles 22 and 24, the walls 26 of which taper parabolically upwards and one
- the wall of the cup can serve as an antenna.
- the curvature of the walls 24 can of course also be designed in a different way than parabolic.
- the antennas 18, 20 comprise a curved reflector 24, by means of which the electromagnetic signals emitted by the activation antenna 18 or transmission antenna 20 are directed onto the transmitter substance 2 or carrier substance 14 or by means of of which the electromagnetic signals emitted by the transmitter material 2 are collected for the receiving antenna 20. In this way the signal transmission is improved.
- the reflector 24 can be made of aluminum, steel or copper, for example.
- the receptacle 22 is encompassed by a first magnetic field coil 28, which in turn is surrounded by a magnetic shielding 30.
- the magnetic field coil 28 serves to generate a defined magnetic field, while the magnetic shield 30 serves to compensate or shield external magnetic fields.
- the receptacle 24 of the carrier material 2 is surrounded in the same way as the receptacle 22 of the transmitter material 2 by a second magnetic field coil 29 and a passive magnetic shield 30. In this way, it is also possible for radiation to swing onto the substrate under defined magnetic field conditions, and an overlay with external magnetic fields is avoided.
- a weak magnetic field between 0 and 1 mT, preferably between 0 and 130 ⁇ T, can be generated in the area of the transmitter material 5 by means of the magnetic coils 28 and 29.
- the transmitter substance 5 can also be a living organism, human, animal or vegetable, or parts thereof.
- Magnetic field sensors Housing Carrier material Activation and receiving antenna Transmitting antenna receptacle Transmitter material receptacle Carrier walls of the receptacles 22, 24 First magnetic field coil Second magnetic field coil Magnetic shielding Control and processing unit
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
Description
Claims
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19746791 | 1997-10-23 | ||
DE19746791 | 1997-10-23 | ||
DE19752934 | 1997-11-28 | ||
DE19752934A DE19752934A1 (de) | 1997-05-23 | 1997-11-28 | Gerät zum Aufschwingen physiologischer Signale auf einen Trägerstoff |
PCT/EP1998/006723 WO1999021614A1 (de) | 1997-10-23 | 1998-10-22 | Vorrichtung und verfahren zum aktivieren von objekten |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1024858A1 true EP1024858A1 (de) | 2000-08-09 |
Family
ID=26041033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98956864A Ceased EP1024858A1 (de) | 1997-10-23 | 1998-10-22 | Vorrichtung und verfahren zum aktivieren von objekten |
Country Status (3)
Country | Link |
---|---|
US (1) | US6425851B1 (de) |
EP (1) | EP1024858A1 (de) |
WO (1) | WO1999021614A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1314389B1 (it) * | 2000-03-03 | 2002-12-13 | Marco Bologna | Dispositivo di generazione di campo elettromedicale |
KR100434690B1 (ko) * | 2002-07-19 | 2004-06-04 | 소광섭 | 생명체에 대한 자기장의 영향을 측정하는 장치 및 방법 |
US8000813B2 (en) * | 2005-08-19 | 2011-08-16 | Old Dominion University Research Foundation | Ultrawideband antenna for operation in tissue |
US20070203655A1 (en) * | 2006-02-27 | 2007-08-30 | Huping Hu | Method and apparatus for producing quantum entanglement and non-local effects of substances |
US20080097142A1 (en) * | 2006-10-20 | 2008-04-24 | Paul Savage | Magnetic field generator, method of generating a pulsed sinusoidal magnetic wave and magnetic field generator system |
CN101534903B (zh) * | 2006-11-08 | 2011-02-09 | 株式会社医疗器械 | 神经营养因子产生促进装置 |
CN102008782B (zh) * | 2006-11-08 | 2014-11-26 | 株式会社P·曼德 | 神经营养因子产生促进装置 |
KR100866378B1 (ko) * | 2007-04-12 | 2008-11-03 | 이승영 | 뇌파를 주요치료정보로 사용하는 저주파 자기물리치료장치 |
WO2009091955A1 (en) * | 2008-01-16 | 2009-07-23 | Issa Salim | Systems and methods for therapeutic treatments |
KR20110092654A (ko) * | 2010-02-10 | 2011-08-18 | 김현원 | 물질 정보 전달 장치 |
US20150173380A1 (en) * | 2012-07-06 | 2015-06-25 | Pier RUBESA | Method and apparatus for the amplification of electrical charges in biological systems or bioactive matter using an inductive disk with a fixed geometric trace |
US10888707B2 (en) | 2013-03-19 | 2021-01-12 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
US10322063B2 (en) | 2013-03-19 | 2019-06-18 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
WO2015143211A1 (en) * | 2014-03-19 | 2015-09-24 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
KR102143550B1 (ko) * | 2019-06-19 | 2020-08-12 | (주)킴스워터 | 물질의 파동을 기억하는 혼합용액을 디지털화하는 방법 |
EP4368172A1 (de) * | 2022-11-11 | 2024-05-15 | Gernot A. Overbeck | Verfahren zur herstellung eines analogen homöopathischen wirkstoffs, vorrichtung zur durchführung des verfahrens und computerprogrammprodukt |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3557777A (en) * | 1967-05-04 | 1971-01-26 | David Cohen | Magnetic study of bioelectric phenomena |
DE3027621A1 (de) | 1980-07-21 | 1982-02-04 | Ludger 6500 Mainz Mersmann | Verfahren und vorrichtungen zur beeinflussung von objekten, wie biologische systeme, stoffe, terrestische bezirke und/oder elektrotechnische geraete |
DE3110915A1 (de) | 1981-03-20 | 1982-12-02 | Ludger 5471 Wassenach Mersmann | Therapiegeraet zur behandlung von wasser und/oder biologischen systemen mit magnetfeldern und/oder elektromagnetischen strahlungen und/oder elektrischen stroemen |
DE3244582A1 (de) | 1982-12-02 | 1984-12-20 | Ludger 5471 Wassenach Mersmann | Therapiegeraet zur beeinflussung und behandlung von biologischen systemen, wie z. b. personen, tiere, pflanzen und/oder wasser, mit magnetfeldern, elektromagnetischen strahlungen, stroemen und/oder optischen strahlungen |
US5100373A (en) * | 1989-01-09 | 1992-03-31 | Life Resonances, Inc. | Techniques for controlling osteoporosis using non-invasive magnetic fields |
US5106361A (en) * | 1988-03-23 | 1992-04-21 | Life Resonances, Inc. | Method and apparatus for controlling the growth of non-osseous non-cartilaginous solid connective tissue |
US4818697A (en) * | 1986-10-27 | 1989-04-04 | Life Resonances, Inc. | Techniques for enhancing the permeability of ions through membranes |
US4932951A (en) * | 1988-03-23 | 1990-06-12 | Life Resonances, Inc. | Method and apparatus for controlling tissue growth and an applied fluctuating magnetic field |
DE4014864A1 (de) * | 1990-05-09 | 1991-11-14 | Rudolf Muehlenbein | Vorrichtung zur abschirmung und absorption sowie zur erzeugung von magnetfeld-strahlung (erdstrahlung) und messanordnung |
US5450859A (en) * | 1991-01-17 | 1995-09-19 | The Catholic University Of America | Protection of living systems from adverse effects of electric, magnetic and electromagnetic fields |
DE4135325A1 (de) | 1991-10-25 | 1993-04-29 | Vega Grieshaber Gmbh & Co | Schwingungs-magnetfeldtherapie-geraet |
US5919679A (en) * | 1994-10-27 | 1999-07-06 | The United States Of America As Represented By The Environmental Protection Agency | Method and apparatus for altering ionic interactions with magnetic fields |
RU2117044C1 (ru) * | 1995-08-25 | 1998-08-10 | Каньчжэн Юрий Владимирович Цзян | Устройство для передачи натурального информационного питания биологическому объекту "биотрон цзян" |
DE29709094U1 (de) | 1997-05-23 | 1998-09-17 | Kiontke, Siegfried, Dr., 81245 München | Gerät für die Bioresonanz-Therapie |
US5997464A (en) * | 1997-08-29 | 1999-12-07 | Orthosoft, L.L.C. | Magnetic coil for pulsed electromagnetic field |
-
1998
- 1998-10-22 EP EP98956864A patent/EP1024858A1/de not_active Ceased
- 1998-10-22 WO PCT/EP1998/006723 patent/WO1999021614A1/de not_active Application Discontinuation
- 1998-10-22 US US09/530,087 patent/US6425851B1/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
See references of WO9921614A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999021614A1 (de) | 1999-05-06 |
US6425851B1 (en) | 2002-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999021614A1 (de) | Vorrichtung und verfahren zum aktivieren von objekten | |
DE69731232T2 (de) | Vorrichtung zur behandlung von pathologischen zuständen mittels elektromagnetischer hautstimulation | |
DE4238829A1 (de) | Einrichtung zur Beeinflussung von elektrischen und magnetischen Feldern niedriger Frequenz | |
EP0136530B1 (de) | Bestrahlungsvorrichtung zur Behandlung von lebendem Gewebe mit elektromagnetischen Wellen | |
DE3110915A1 (de) | Therapiegeraet zur behandlung von wasser und/oder biologischen systemen mit magnetfeldern und/oder elektromagnetischen strahlungen und/oder elektrischen stroemen | |
EP2944350B1 (de) | Therapievorrichtung | |
DE8532628U1 (de) | Kombiniertes Magnetfeld-Infrarot-Behandlungsgerät | |
EP3289781B1 (de) | Ultraschallpulse aussendende hörprothese | |
DE29709094U1 (de) | Gerät für die Bioresonanz-Therapie | |
DE19752934A1 (de) | Gerät zum Aufschwingen physiologischer Signale auf einen Trägerstoff | |
DE10157024B4 (de) | Vorrichtung zur Erzeugung von pulsierenden elektromagnetischen und/oder elektrischen Feldern | |
EP0023311B1 (de) | Medizinisches Bestrahlungsgerät | |
EP3282840A1 (de) | Verfahren und vorrichtung zur erzeugung von elektromagnetischen feldern, die das nervensystem von insekten beeinflussen | |
DE3752289T2 (de) | Tragbares Elektrotherapiesystem | |
EP4072651B1 (de) | Therapievorrichtung zur zelltherapie oder zellstimulation | |
EP0765176A1 (de) | Vorrichtung zur beeinflussung von elektromagnetischen schwingungsfeldern, insbesondere von funkwellen | |
DE102017123854A1 (de) | Magnetfeldapplikator zur Magnetstimulation von Körpergewebe mit körperlich wahrnehmbarer Rückmeldung | |
EP3586917A1 (de) | Vorrichtung und methode zur aktivierung von zellstrukturen mittels elektromagnetischer energie | |
DE1805284A1 (de) | Verfahren zur Aufbereitung von Schwingungstraegern als Mittel fuer die Erkennung und Behandlung von Krankheiten | |
DE69632134T2 (de) | Vorrichtung zur behandlung eines organismus mit energie | |
WO2025002828A1 (de) | Vorrichtung zur durchführung einer hochfrequenz-elektrotherapie sowie verfahren zum bestimmen einer geeigneten trägerfrequenz | |
DE102020208431B4 (de) | Nicht-invasive Dynamic Coordinated Reset (DCR) Stimulation | |
DE19920706A1 (de) | Vorrichtung zum Erzeugen einer tiefinfraroten Strahlung und Anzeigevorrichtung, die eine derartige Strahlung verwendet | |
DE19529967C2 (de) | Verfahren zur Erhöhung der elektromagnetischen Verträglichkeit von Geräten sowie Datenträger hierfür | |
DE202012006092U1 (de) | Therapievorrichtung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000515 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20030415 |
|
APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
APAA | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOS REFN |
|
APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |
|
APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20070306 |